Cytotoxicity of Gold Complexes
Author Information
Author(s): Dick de Vos, Phil Clements, Simon M. Pyke, Douglas R. Smyth, Edward R.T. Tiekink
Primary Institution: Medical Department, Pharmachemie B.V.
Hypothesis
The study investigates the in vitro cytotoxicity of triorganophosphinegold(I) 2-mercaptobenzoate complexes against human tumor cell lines.
Conclusion
The gold complexes exhibit moderate to very high cytotoxicity, particularly against the H226 cell line, outperforming several established cytotoxic drugs.
Supporting Evidence
- The complexes showed very high to moderate cytotoxicity with ID50 values ranging from <250 ng/ml to 250-2500 ng/ml.
- The R Et derivatives were the most active against the tested cell lines.
- The gold complexes were significantly more active than cisplatin against the A498 and H226 cell lines.
- The study included a range of human tumor cell lines including breast, colon, ovarian, melanoma, renal, and lung cancers.
Takeaway
The researchers tested some gold compounds to see if they could kill cancer cells, and they found that some worked really well, especially against lung cancer cells.
Methodology
The cytotoxicity was assessed using the microculture sulforhodamine B (SRB) test on seven human tumor cell lines.
Limitations
The study does not confirm whether the observed in vitro activity is maintained in vivo.
Want to read the original?
Access the complete publication on the publisher's website